DNLI Company Information
Denali Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
California, USA
Denali Therapeutics Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Denali Therapeutics Inc
Current Price
$18.62
-3.97%Profile
Valuation (TTM)
Market Cap$2.95B
P/E-5.81
EV—
P/B2.91
Shares Out158.59M
P/Sales—
Revenue$0.00
EV/EBITDA—
Denali Therapeutics Inc (DNLI) Company Profile
DNLI Key Officers
Key officers data coming soon
DNLI Company Profile
Denali Therapeutics Inc (DNLI) is a Healthcare company in the Biotechnology industry. It trades on NASDAQ. The company is based in California, USA.
Denali Therapeutics Inc
Market cap is $2.95B. There are 158.6M shares outstanding.
See the full Denali Therapeutics Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if DNLI is a good investment.